Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

1.3K
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
1.3K
Atypical Pneumonia01:14

Atypical Pneumonia

17
Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease...
17
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

1.2K
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
1.2K
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

4.0K
The pathophysiology of pneumonia involves the following steps:
4.0K
Pneumonia IV: Management01:28

Pneumonia IV: Management

1.0K
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
1.0K
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

3.9K
Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
3.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Evolving Burden of Colorectal Cancer in South Asia: A GBD-Based Analysis of Trends, Risk Factors, and Projections to 2035.

Journal of gastrointestinal cancer·2026
Same author

From Resuscitation to Rehabilitation: The Post-Intensive Care Syndrome Continuum in Sepsis Care.

Journal of clinical medicine·2025
Same author

Evaluation of the Modified Early Warning Score (MEWS) in In-Hospital Cardiac Arrest in a Tertiary Healthcare Facility.

Journal of clinical medicine·2025
Same author

Overview and management of hepatorenal syndrome.

Current opinion in anaesthesiology·2025
Same author

Sepsis Care: Cardiovascular Challenges and Solutions for Nurses.

Critical care nursing quarterly·2025
Same author

Sepsis Epidemiology, Definitions, Scoring Systems, and Diagnostic Markers.

Critical care nursing quarterly·2025
Same journal

The Relationship Between Ethical Ideology and Moral Resilience in Critical Care Nurses.

Critical care nursing quarterly·2026
Same journal

The Effect of Monitor Alarm Management Training on the Level of Alarm Fatigue of Nurses in Intensive Care Units.

Critical care nursing quarterly·2026
Same journal

Oral Care in Patients With Invasive Airway Management in the ICU: A Prospective Observational Study.

Critical care nursing quarterly·2026
Same journal

Nurses' Perceived Barriers to the Implementation and Sustainability of Best Patient Safety in Handover in the Clinical Setting: Cross-Sectional Survey Study.

Critical care nursing quarterly·2026
Same journal

Association Between Early Tracheostomy and Patient Outcomes in Critically Ill Patients on Mechanical Ventilator: A Retrospective Cohort Study.

Critical care nursing quarterly·2026
Same journal

Nurses' Knowledge of Blood Transfusion Safety at Intensive Care Units in Jordan: A Cross-Sectional Study.

Critical care nursing quarterly·2026
See all related articles

Related Experiment Video

Updated: Mar 25, 2026

Experimental Model to Evaluate Resolution of Pneumonia
09:49

Experimental Model to Evaluate Resolution of Pneumonia

Published on: February 17, 2023

2.0K

Acute Pneumonia.

Hammad Arshad1, Adebayo Fasanya, Tariq Cheema

  • 1Department of Pulmonary and Critical Care, Allegheny Health Network/Allegheny General Hospital, Pittsburgh, Pennsylvania.

Critical Care Nursing Quarterly
|February 27, 2016
PubMed
Summary
This summary is machine-generated.

Acute pneumonia, a leading infectious cause of death in the US, presents different challenges in community versus healthcare settings. Emerging resistant organisms and an aging population continue to pose substantial mortality risks.

More Related Videos

Methods for Detecting Cytotoxic Amyloids Following Infection of Pulmonary Endothelial Cells by Pseudomonas aeruginosa
07:27

Methods for Detecting Cytotoxic Amyloids Following Infection of Pulmonary Endothelial Cells by Pseudomonas aeruginosa

Published on: July 12, 2018

6.0K
Pseudomonas aeruginosa Induced Lung Injury Model
07:24

Pseudomonas aeruginosa Induced Lung Injury Model

Published on: October 29, 2014

19.2K

Related Experiment Videos

Last Updated: Mar 25, 2026

Experimental Model to Evaluate Resolution of Pneumonia
09:49

Experimental Model to Evaluate Resolution of Pneumonia

Published on: February 17, 2023

2.0K
Methods for Detecting Cytotoxic Amyloids Following Infection of Pulmonary Endothelial Cells by Pseudomonas aeruginosa
07:27

Methods for Detecting Cytotoxic Amyloids Following Infection of Pulmonary Endothelial Cells by Pseudomonas aeruginosa

Published on: July 12, 2018

6.0K
Pseudomonas aeruginosa Induced Lung Injury Model
07:24

Pseudomonas aeruginosa Induced Lung Injury Model

Published on: October 29, 2014

19.2K

Area of Science:

  • Pulmonary Medicine
  • Infectious Diseases
  • Critical Care Medicine

Background:

  • Acute pneumonia is a significant cause of infection-related mortality in the United States.
  • Pneumonia presents distinct risk factors, pathogenesis, and causative agents in community-acquired versus healthcare-associated settings.
  • Despite improved management guidelines, substantial mortality risks persist.

Purpose of the Study:

  • To summarize the epidemiology and challenges of acute pneumonia.
  • To highlight the differences between community-acquired and healthcare-associated pneumonia.
  • To underscore the impact of multidrug-resistant organisms and an aging population on pneumonia outcomes.

Main Methods:

  • Literature review and synthesis of current knowledge on acute pneumonia.
  • Analysis of epidemiological data and risk factors.
  • Discussion of evolving challenges in pneumonia management.

Main Results:

  • Acute pneumonia remains a leading cause of death from infection.
  • Community-acquired and healthcare-associated pneumonia exhibit different etiological profiles and risk factors.
  • Multidrug-resistant organisms and the elderly demographic contribute to high mortality rates.

Conclusions:

  • Effective management of acute pneumonia requires addressing setting-specific factors.
  • The rise of antimicrobial resistance and an aging population necessitate ongoing vigilance and research.
  • Continued development of guidelines and therapeutic strategies is crucial for reducing pneumonia-related mortality.